Young, Ginger
Bohning, Kelly J.
Zahralban-Steele, Melissa
Hather, Greg
Tadepalli, Sambasivarao
Mickey, Kristen
Godin, C. Steven
Sanisetty, Srisowmya
Sonnberg, Stephanie
Patel, Hetal K.
Dean, Hansi J.
Funding for this research was provided by:
Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority (HHSO100201600015C, HHSO100201600015C, HHSO100201600015C, HHSO100201600015C, HHSO100201600015C, HHSO100201600015C, HHSO100201600015C, HHSO100201600015C, HHSO100201600015C, HHSO100201600015C)
Takeda Vaccines, Inc.
Article History
Received: 17 December 2019
Accepted: 12 February 2020
First Online: 26 February 2020
Competing interests
: G.Y., K.J.B., M.Z., G.H., S. Sonnberg, H.K.P. and H.J.D. are employees of Takeda. S. Sanisetty was a contract researcher on assignment with Takeda. S.T. works as an employee of Charles River Laboratories, contracted by Takeda. K.M. works as an employee of Viracor Eurofins, contracted by Takeda. C.S.G. works as an employee of Inotiv, contracted by Takeda.